BD gets FDA approval for Surgiphor 1,000 ml antimicrobial irrigation system

USA—Becton, Dickinson and Company (BD) has received US Food and Drug Administration (FDA) 510(k) clearance for its Surgiphor 1,000ml antimicrobial irrigation system.

The medical device company designed this powered lavage solution specifically for operating room workflows, representing a significant step forward in standardizing surgical wound cleaning procedures.

The newly cleared system allows clinicians to mechanically loosen and remove debris and microorganisms from wounds during powered irrigation procedures.

By delivering consistent performance across various surgical interventions, Surgiphor 1,000ml simplifies complex wound care processes while maintaining ease of use for surgical teams.

Ready-to-use design streamlines surgical preparation

BD delivers Surgiphor 1,000ml as a ready-to-use, sterile product that eliminates the need for manual mixing for hospital staff.

This streamlined approach helps hospitals comply with international safety guidelines for wound cleaning while reducing operating room preparation time.

The system’s higher-volume configuration expands BD’s existing Surgiphor portfolio, providing surgical teams with additional options that integrate seamlessly into current powered irrigation setups.

Comprehensive compatibility and user-friendly features

The irrigation system works with many established powered lavage devices already in use across healthcare facilities.

BD equipped the Surgiphor 1,000 ml with several practical features, including a powered-device adapter, a Y-connector that allows clinicians to switch between saline and Surgiphor solutions, and a twist cap for manual application when necessary.

The system incorporates an integrated venting mechanism that ensures smooth fluid flow throughout procedures, while its collapsible bottle design facilitates easier evacuation and handling during surgical operations.

Surgiphor 1,000 ml contains a terminally sterile povidone-iodine (PVP-I) solution that BD manufactures in multiple sizes and formats to accommodate different clinical needs.

The company positions this flexibility as a key advantage for operating room teams managing a diverse range of surgical cases.

Industry leadership in surgical irrigation

Rian Seger, worldwide president of the BD Surgery business, emphasized that the FDA clearance strengthens BD’s position as the global leader in surgical irrigation innovation.

He highlighted that Surgiphor 1,000ml delivers the consistency and safety that surgical teams have come to expect from BD products.

Seger noted that this unique solution allows healthcare professionals to concentrate on their primary objective: providing better, safer care for their patients.

Recent partnership developments

BD continues to expand its medical device offerings through strategic collaborations.

In January 2026, the company and Ypsomed announced an extension of their partnership to develop a 5.5 ml version of the BD Neopak XtraFlow glass prefillable syringe.

This collaboration demonstrates BD’s ongoing commitment to advancing medical device technology across multiple product categories beyond surgical irrigation systems.

The Surgiphor 1,000 ml antimicrobial irrigation system is now available for use in US healthcare facilities following the FDA clearance.